Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/10/2022* -- Results Q3 2022 -- 0.70 --
11/10/2022* 08:30 EST Earnings Call Q3 2022 -- -- --
08/09/2022 -- Results Q2 2022 0.43 0.44 -2.60%
08/09/2022 08:30 EST Earnings Call Q2 2022 -- -- --
05/11/2022 -- Results Q1 2022 0.33 0.42 -21.56%
05/11/2022 08:30 EST Earnings Call Q1 2022 -- -- --
03/01/2022 -- Results Q4 2021 0.60 0.56 6.66%
03/01/2022 08:30 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/10/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/09/2022
Beat/Miss Upgrade
Return Since -13.61%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
URL https://www.perrigo.com
Investor Relations URL https://investor.perrigo.com/
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Value
Next Earnings Release Nov. 10, 2022 (est.)
Last Earnings Release Aug. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 01, 2022

Dividends

Dividend Per Share (TTM) 1.00
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 1.947
Yield to Sector 1.550
Yield to Industry 1.032
Last Dividend Amt. 0.26
Dividend Frequency Quarterly
Last Ex-Dividend Date Sep. 01, 2022
Yield (TTM) 2.86%
Forward Yield 2.92%
Payout Ratio -114.8%
Cash Payout Ratio 79.73%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
-13.18%
-42.14%
5.59%
-55.08%
35.65%
-11.92%
-10.96%
-6.40%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-23.87%
35.55%
-29.98%
-1.53%
-46.08%
-30.87%
-2.21%
16.59%
-4.00%
-14.15%
-22.43%
23.50%
-7.94%
20.43%
10.56%
-22.81%
4.62%
--
--
--
--
-10.18%
-78.02%
-60.38%
-72.43%
68.11%
-25.33%
-9.77%
33.84%
85.26%
102.1%
47.31%
-42.57%
As of September 30, 2022.

Profile

Edit
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
URL https://www.perrigo.com
Investor Relations URL https://investor.perrigo.com/
HQ State/Province N/A
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Equity Style Small Cap/Value
Next Earnings Release Nov. 10, 2022 (est.)
Last Earnings Release Aug. 09, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date Sep. 01, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
DSCPX 25.28M USD 4.64%
SSHVX 40.80M USD 4.08%
XPH 7.158M USD 3.38%
PJP 9.746M USD 3.19%
SMIG 3.416M USD 3.11%
COHOX 24.77M USD 2.58%
HNTVX 16.23M USD 2.58%
IHE 7.847M USD 2.02%
MCVCX 26.39M USD 1.87%
GRX 3.935M USD 1.35%
PPH 6.478M USD 1.16%
CSVRX 12.89M USD 1.01%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PRGO Tweets